These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 3003449)

  • 21. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine.
    Asano Y; Nakayama H; Yazaki T; Kato R; Hirose S
    Pediatrics; 1977 Jan; 59(1):3-7. PubMed ID: 190583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella vaccination in HIV-1-infected children after immune reconstitution.
    Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
    AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
    Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.
    Sugino H; Tsukino R; Miyashiro E; Dezawa T; Shinohara K; Uemura S; Koike M
    Biken J; 1984 Sep; 27(2-3):63-5. PubMed ID: 6100060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early results of a trial of the Oka-strain varicella vaccine in children with leukaemia or other malignancies in Sweden.
    Heller L; Berglund G; Ahström L; Hellstrand K; Wahren B
    Postgrad Med J; 1985; 61 Suppl 4():79-83. PubMed ID: 3014483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with the live Oka-strain varicella vaccine in children with solid tumours.
    Heath RB; Malpas JS
    Postgrad Med J; 1985; 61 Suppl 4(721):107-11. PubMed ID: 3014467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of live varicella vaccine in children with acute leukemia and malignant lymphoma.
    Sato Y; Miyano T; Kawauchi K; Yokoyama M
    Biken J; 1984 Sep; 27(2-3):111-3. PubMed ID: 6100046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
    Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
    Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy.
    Nunoue T
    Biken J; 1984 Sep; 27(2-3):115-8. PubMed ID: 6100047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella vaccine studies in healthy children and adults.
    Arbeter AM; Starr SE; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):748-56. PubMed ID: 3020494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live attenuated varicella vaccine in children with leukemia in remission.
    Gershon AA; Steinberg S; Galasso G; Borkowsky W; Larussa P; Ferrara A; Gelb L
    Biken J; 1984 Sep; 27(2-3):77-81. PubMed ID: 6100063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.